Romosozumab Versus Denosumab in GIOP: a 2-year Extension Study

PHASE4RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 20, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions

OsteoporosisGlucocorticoids Toxicity

Interventions

DRUG

Romosozumab

osteoporosis treatment

DRUG

Denosumab

osteoporosis treatment

Trial Locations (1)

RECRUITING

Department of Medicine, Tuen Mun Hospital, Hong Kong

All Listed Sponsors

lead

Tuen Mun Hospital

OTHER_GOV